APA ציטוט

Ikenaga, N., Peng, Z., Vaid, K. A., Liu, S. B., Yoshida, S., Sverdlov, D. Y., . . . Popov, Y. V. (2017). Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal. Gut.

Citação norma Chicago

Ikenaga, Naoki, et al. "Selective Targeting of Lysyl Oxidase-like 2 (LOXL2) Suppresses Hepatic Fibrosis Progression and Accelerates Its Reversal." Gut 2017.

ציטוט MLA

Ikenaga, Naoki, et al. "Selective Targeting of Lysyl Oxidase-like 2 (LOXL2) Suppresses Hepatic Fibrosis Progression and Accelerates Its Reversal." Gut 2017.